Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Saratoga Investment Corp is an asset management business based in the US. Saratoga Investment shares (SAR) are listed on the NYSE and all prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $24.22 |
|---|---|
| 52-week range | $22.35 - $28.57 |
| 50-day moving average | $25.52 |
| 200-day moving average | $27.54 |
| Wall St. target price | $30.42 |
| PE ratio | 6.0702 |
| Dividend yield | $2.02 (8.71%) |
| Earnings per share (TTM) | $3.99 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $24.22 from 2022-07-01
| 1 week (2022-06-29) | 1.68% |
|---|---|
| 1 month (2022-06-02) | -8.74% |
| 3 months (2022-04-02) | N/A |
| 6 months (2022-01-06) | -13.68% |
| 1 year (2021-07-06) | -10.50% |
|---|---|
| 2 years (2020-07-06) | 58.82% |
| 3 years (2019-07-05) | 0.37% |
| 5 years (2017-07-05) | 11.15% |
Valuing Saratoga Investment stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Saratoga Investment's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Saratoga Investment's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6x. In other words, Saratoga Investment shares trade at around 6x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Revenue TTM | $70.7 million |
|---|---|
| Operating margin TTM | 57.13% |
| Gross profit TTM | $70.7 million |
| Return on assets TTM | 3.44% |
| Return on equity TTM | 13.86% |
| Profit margin | 64.65% |
| Book value | $29.33 |
| Market capitalisation | $293.6 million |
TTM: trailing 12 months
Dividend payout ratio: 105.5% of net profits
Recently Saratoga Investment has paid out, on average, around 105.5% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 8.71% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Saratoga Investment shareholders could enjoy a 8.71% return on their shares, in the form of dividend payments. In Saratoga Investment's case, that would currently equate to about $2.02 per share.
Saratoga Investment's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Saratoga Investment's most recent dividend payout was on 28 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 12 June 2022 (the "ex-dividend date").
Saratoga Investment's shares were split on a 1:10 basis on 12 August 2010. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Saratoga Investment shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Saratoga Investment shares which in turn could have impacted Saratoga Investment's share price.
Over the last 12 months, Saratoga Investment's shares have ranged in value from as little as $22.35 up to $28.5676. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Saratoga Investment's is 1.5045. This would suggest that Saratoga Investment's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Saratoga Investment Corp. is a business development company specializing in leveraged and management buyouts, acquisition financings, growth financings, recapitalization, debt refinancing, and transitional financing transactions at the lower end of middle market companies. It structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, co-investments, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity. The firm prefers to invest in aerospace, automotive aftermarket and services, business products and services, consumer products and services, education, environmental services, industrial services, financial services, food and beverage, healthcare products and services, logistics, distribution, manufacturing, restaurants services, food services, software services, technology services, specialty chemical, media and telecommunications. It seeks to invest in the United States. The firm primarily invests $5 million to $50 million in companies having EBITDA of $2 million or greater and revenues of $8 million to $250 million. The firm prefer to take a majority stake.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.